Literature DB >> 32485140

Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis.

Rongzhong Huang1, Suetonia C Palmer2, Yu Cao3, Hong Zhang4, Yang Sun5, Wenhua Su4, Liwen Liang4, Sanrong Wang6, Ying Wang6, Yu Xu7, Narayan D Melgiri8, Lihong Jiang3, Giovanni F M Strippoli9, Xingsheng Li10.   

Abstract

BACKGROUND: Cardiac rehabilitation is a medically supervised program after coronary events that involves exercise and dietary modification. We evaluated the comparative benefits and harms of cardiac rehabilitation strategies via a network meta-analysis.
METHODS: We followed a pre-specified protocol (PROSPERO: CRD42018094998). We searched Embase, MEDLINE, and Cochrane Central Register of Randomized Trials databases for randomized controlled trials that evaluated cardiac rehabilitation vs a second form of rehabilitation or standard/usual care in adults after myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, or angiography. Risk of bias and evidence quality was evaluated using the Cochrane tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE), respectively. Pairwise and Bayesian network meta-analyses were performed for 11 clinical outcomes.
RESULTS: We included 134 randomized controlled trials involving 62,322 participants. Compared with standard care, exercise-only cardiac rehabilitation reduced the odds of cardiovascular mortality (odds ratio [OR], 0.70; 95% credibility interval [CrI], 0.51-0.96; moderate-quality evidence), major adverse cardiovascular events (OR, 0.57; 95% CrI, 0.40-0.78; low-quality evidence), nonfatal myocardial infarction (OR, 0.71; 95% CrI, 0.54-0.93; moderate-quality evidence), all-cause hospitalization (OR, 0.74; 95% CrI, 0.54-0.98; moderate-quality evidence), and cardiovascular hospitalization (OR, 0.69; 95% CrI, 0.51-0.88; moderate-quality evidence). Exercise-only cardiac rehabilitation was associated with lower cardiovascular hospitalization risk relative to cardiac rehabilitation without exercise (OR, 0.68; 95% CrI, 0.48-0.97; moderate-quality evidence).
CONCLUSIONS: Cardiac rehabilitation programs containing exercise might provide broader cardiovascular benefits compared with those without exercise.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32485140     DOI: 10.1016/j.cjca.2020.02.072

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Cardiac rehabilitation for older adults: current evidence and future potential.

Authors:  Maha A Alfaraidhy; Claire Regan; Daniel E Forman
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-02-13

Review 2.  Exercise-based cardiac rehabilitation for coronary heart disease.

Authors:  Grace Dibben; James Faulkner; Neil Oldridge; Karen Rees; David R Thompson; Ann-Dorthe Zwisler; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2021-11-06

Review 3.  Systematic Review of Interventions Designed to Maintain or Increase Physical Activity Post-Cardiac Rehabilitation Phase II.

Authors:  Helen Graham; Kathy Prue-Owens; Jess Kirby; Mythreyi Ramesh
Journal:  Rehabil Process Outcome       Date:  2020-08-25

4.  Participant Exercise-Session Attendance in Community-Based, Bridging, and Hospital-Based Cardiac Rehabilitation: A Retrospective Case-Control Study.

Authors:  Stephanie K Nathanail; Gabor T Gyenes; Andrea Van Damme; Tara C Meyer; Eric C Parent; Michael D Kennedy
Journal:  CJC Open       Date:  2021-12-09

5.  Quality of Care Indicators for Hospital Physical Therapy Units: A Systematic Review.

Authors:  Daniel Angel-Garcia; Ismael Martinez-Nicolas; Bianca Salmeri; Alizée Monot
Journal:  Phys Ther       Date:  2022-02-01

6.  Efficacy and safety of different modes of exercise-based cardiac rehabilitation delivery for patients with heart failure: a protocol for a systematic review and network meta-analysis.

Authors:  Lingjun Jiang; Ruixuan Wan; Bohan Li; XuHui Huang; Yaning Xu; Kaisong Wu; Jie Xu; Yan Lu
Journal:  BMJ Open       Date:  2022-08-04       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.